![Lynne Bui](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lynne Bui
Chief Executive Officer at
Khloris Biosciences, Inc.
Profile
Dr. Lynne A. Bui, MD, is a Chairman at GCRI Foundation, Inc., a Chairman at Global Cancer Research Institute and a President, Chief Executive Officer & Director at Khloris Biosciences, Inc. Dr. Bui was previously employed as an Independent Director by Tharimmune, Inc., a Chief Medical Officer by Exelixis, Inc., a Chief Medical Officer by Intellikine LLC, and a Chief Medical Officer by Onyx Pharmaceuticals, Inc. She received her undergraduate degree from the University of California, Berkeley and a graduate degree from David Geffen School of Medicine.
Lynne Bui active positions
| Companies | Position | Start |
|---|---|---|
Khloris Biosciences, Inc.
 Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Chief Executive Officer | 2017-05-31 |
Global Cancer Research Institute | Founder | - |
GCRI Foundation, Inc. | Founder | - |
Former positions of Lynne Bui
| Companies | Position | End |
|---|---|---|
| CANTON STRATEGIC HOLDINGS, INC. | Director/Board Member | 2025-06-09 |
Intellikine LLC
 Intellikine LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs for the treatment of cancer | Chief Tech/Sci/R&D Officer | - |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Chief Tech/Sci/R&D Officer | - |
| EXELIXIS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Lynne Bui
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellikine LLC
Intellikine LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs for the treatment of cancer | Health Technology |
David Geffen School of Medicine
 David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Khloris Biosciences, Inc.
Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Commercial Services |
Tharimmune, Inc.
 Tharimmune, Inc. BiotechnologyHealth Technology Operates as a pre-clinical biotechnology company that develops novel therapeutic candidates targeting ferroptosis | Health Technology |
Global Cancer Research Institute | |
GCRI Foundation, Inc. |
- Stock Market
- Insiders
- Lynne Bui
